Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation.

Atrial fibrillation is the most frequently diagnosed cardiac arrhythmia globally and is associated with ischemic stroke and heart failure. Patients with atrial fibrillation are typically prescribed...